anti-GLUT-4 mAbs (Integral Molecular)

N/A

Report date: 2025/06/11 11:04:07

Base Information

Drug Nameanti-GLUT-4 mAbs (Integral Molecular)
Drug Alias NameLM-052LM-043LM-048LM-059
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionInsulin sensitizersGlucose transporter type 4 inhibitors
TargetsGlucose transporter type 4
Therapy Area/IndicationsDiabetes MellitusMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIntegral Molecular Inc
China Registration ClassN/A

Develop Information

Active CompaniesIntegral Molecular Inc
Inactive CompaniesN/A
Active IndicationsDiabetes MellitusMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A